Evrofarma (ATH:EVROF) Loans Receivable: €0.00 Mil (As of . 20)


What is Evrofarma Loans Receivable?

Evrofarma ATH:EVROF -0.53% Loans Receivable is €0.00 Mil as of . 20.

Evrofarma's Loans Receivable for the quarter that ended in . 20 was €0.00 Mil.

Evrofarma Loans Receivable Historical Data

* Premium members only.

The historical data trend for Evrofarma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evrofarma Loans Receivable Chart

Evrofarma Annual Data
Trend
Loans Receivable

Evrofarma Quarterly Data
Loans Receivable

Evrofarma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.00 Mil mean?
Evrofarma (ATH:EVROF) has a Loans Receivable of €0.00 Mil as of . 20. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Evrofarma and its competitors.
Is Evrofarma's Loans Receivable too high?
Evrofarma's current Loans Receivable is €0.00 Mil.
How does Evrofarma's Loans Receivable compare to FAMI and VATE?
Evrofarma's Loans Receivable of €0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Consumer Packaged Goods company?
A good Loans Receivable depends on the Consumer Packaged Goods industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Evrofarma and its competitors. Evrofarma's current Loans Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evrofarma stock overvalued right now?
Evrofarma (ATH:EVROF) has a current Loans Receivable of €0.00 Mil. The current Loans Receivable is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Evrofarma (ATH:EVROF), the current Loans Receivable is €0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evrofarma Business Description

Address 1st km Didimoticho-Orestiada, Didimoticho, GRC, 68300
Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.